Friday, December 23, 2016 Written by Cepheid

Just the Facts

Preventing further complications in patients who develop infections after surgery to replace a knee or hip could save the U.S. healthcare system as much as $65 million annually, according to an analysis presented at the APIC Annual meeting in June.*

Rehospitalizations after treatment for Surgical Site Infections add $10–65 million to healthcare costs annually in the United States.*

In the APIC study, subsequent rehospitalizations for Surgical Site Infections were associated with an average hospital stay of 8.6 days, costing on average $26,812.*

According to the Centers for Disease Control and Prevention, infections develop in about 1 to 3 out of every 100 patients who have surgery.*

*All Facts from a June 4, 2012 Press Release titled “Rehospitalizations after treatment for surgical site infections add $10–65 million to healthcare costs: new analysis” by the Association for Professionals in Infection Control and Epidemiology (APIC)


Excellence in access to innovation and quality are what make the Clinique des Cèdres a pioneer in managing infectious disease risk. Our institution is owned by a group of physicians rather than a private health organization. This gives us the freedom to invest in medically innovative technology, such as our partnership with Cepheid to prevent healthcare-associated infections.

The GeneXpert® Infinity-80 will truly impact our institution by adding medical value. Obtaining rapid results will improve patient management, providing a better control of bacteria transmission and will decrease the patients’ length of stay. More importantly, this innovation will enable us to improve the safety of our patients.”

- Dr. Guillaume Richalet CEO of the Clinique des Cèdres, Echirolles, France